Maximizing shareholder value is (literally) killing us

By Brian Callaci

“We depend on the research and development efforts of pharmaceutical companies to develop treatments for the most dangerous diseases on the planet, but the largest of those companies appear more interested in financial engineering than creating lifesaving drugs.”…

[Click HERE to read the full article]